Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.800
+0.085 (4.96%)
At close: Dec 20, 2024, 4:00 PM
1.780
-0.020 (-1.11%)
After-hours: Dec 20, 2024, 5:52 PM EST
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $119.23 million as of December 20, 2024. Its market cap has decreased by -6.45% in one year.
Market Cap
119.23M
Enterprise Value
96.83M
1-Year Change
-6.45%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $119.23M, a decrease of -67.20%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 119.23M | 65.81% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | 199.81M | -49.04% |
| Dec 31, 2019 | 392.14M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| American Well | 120.11M |
| Applied Therapeutics | 118.68M |
| Sensus Healthcare | 118.17M |
| Zomedica | 117.59M |
| Allakos | 115.25M |
| Cabaletta Bio | 112.91M |
| Tenaya Therapeutics | 111.70M |
| Lineage Cell Therapeutics | 110.65M |